Cordyceps sinensis and cordyceps militaris offer many clinical and pharmacological properties for curing various disorders. It has been used as a remedy for around 21 ailments such as high blood pressure, low immunity, etc. Moreover, researchers and clinical labs are focused evaluating the medicinal properties of cordyceps to treat various chronic disorders such as arthritis and cancer. However, clinical trials and scientific studies have found that cordyceps sinensis extract can be used to treat of hypertension, high cholesterol, and diabetes. It also acts as a stress reliever in stress related disorders and help boost immunity.
Increasing prevalence of chronic diseases, such as cancer, respiratory diseases, diabetes, and heart disease is driving the cordyceps sinensis and militaris extract market growth. Cordyceps sinensis extract has anti-cancer properties and can be used to treat liver-associated diseases. According to the World Health Organization (WHO), heart diseases cause more than 17.9 million deaths each year, followed by diabetes (1.6 million), respiratory illnesses (3.9 million), and cancer (9 million), respectively. Thus, with the increasing prevalence of aforementioned diseases, the demand for cordyceps sinensis extract is also increasing, which in turn, is expected to augment the cordyceps sinensis and militaris extract market growth.
Cordyceps sinensis extract offers various medicinal properties, such as help increase efficiency of the circulatory system, reduce cholesterol, stimulate immune system, faster recovery from bronchitis, and faster recovery from other respiratory diseases. Militaris are potential herbal therapeutic bio-metabolites. Such cordyceps have shown considerable importance for many clinical and biotechnological applications. Furthermore, the growth of the cordyceps sinensis and militaris extract market is driven by the growing demand for herbal medicine and rising Traditional Chinese Medicine (TCM) in primary healthcare.
TCM includes, herbal extracts, Chinese medicinal products, and healthcare products. TCM goods help other regions or countries to grow and export conventional medicines to support the pharmaceutical industry. Moreover, the United States Food and Drug Administration (FDA) has approved the use of cordyceps sinensis extract as dietary supplement. Thus, market players are focused on developing products for multiple end-use including dietary supplements, food products, and medicines. Majority of the manufacturers are now focused on producing cordyceps extract powder to produce other pharmaceutical formulations.
However, high cost of cordyceps sinensis is a major factor restraining the cordyceps sinensis and militaris extract market growth. Adoption of such expensive TCM is low in emerging economies such as Latin America and Africa.
No comments:
Post a Comment